Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06643585 |
| Title | A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse (SURVIVE HERoes) |
| Acronym | SURVIVE HERoes |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Prof. Wolfgang Janni |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |